Published in PLoS One on October 06, 2011
Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol (2013) 1.64
An update on primary hyperoxaluria. Nat Rev Nephrol (2012) 1.54
Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria. J Am Soc Nephrol (2015) 1.18
Metabolism of [13C5]hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria. Am J Physiol Gastrointest Liver Physiol (2011) 1.03
4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition. Biochim Biophys Acta (2012) 0.94
Identification and characterization of D-hydroxyproline dehydrogenase and Delta1-pyrroline-4-hydroxy-2-carboxylate deaminase involved in novel L-hydroxyproline metabolism of bacteria: metabolic convergent evolution. J Biol Chem (2012) 0.93
Proline dehydrogenase 2 (PRODH2) is a hydroxyproline dehydrogenase (HYPDH) and molecular target for treating primary hyperoxaluria. Biochem J (2015) 0.88
Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies. Eur J Hum Genet (2012) 0.88
Hydroxyproline metabolism in a mouse model of Primary Hyperoxaluria Type 3. Biochim Biophys Acta (2015) 0.80
mRNA N6-methyladenosine methylation of postnatal liver development in pig. PLoS One (2017) 0.75
Use of a novel microtitration protocol to obtain diffraction-quality crystals of 4-hydroxy-2-oxoglutarate aldolase from Bos taurus. Acta Crystallogr F Struct Biol Commun (2014) 0.75
Kidney stone analysis: "Give me your stone, I will tell you who you are!". World J Urol (2014) 0.75
Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystallogr (1997) 137.43
PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr (2010) 108.52
Phaser crystallographic software. J Appl Crystallogr (2007) 108.34
Features and development of Coot. Acta Crystallogr D Biol Crystallogr (2010) 89.46
MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr (2009) 53.36
PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallogr D Biol Crystallogr (2004) 23.86
The finer things in X-ray diffraction data collection. Acta Crystallogr D Biol Crystallogr (1999) 19.10
Version 1.2 of the Crystallography and NMR system. Nat Protoc (2007) 13.01
Sedimentation equilibrium analysis of protein interactions with global implicit mass conservation constraints and systematic noise decomposition. Anal Biochem (2004) 3.71
Metabolism of proline and the hydroxyprolines. Annu Rev Biochem (1980) 2.91
Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Kidney Int (2006) 2.72
The primary hyperoxalurias. Kidney Int (2009) 2.53
Mutations in DHDPSL are responsible for primary hyperoxaluria type III. Am J Hum Genet (2010) 2.32
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin J Am Soc Nephrol (2011) 1.79
Glyoxylate synthesis, and its modulation and influence on oxalate synthesis. J Urol (1998) 1.70
Urinary excretion of hydroxyproline in health and disease. Int Rev Connect Tissue Res (1970) 1.70
Molecular etiology of primary hyperoxaluria type 1: new directions for treatment. Am J Nephrol (2005) 1.66
Mechanism of the Class I KDPG aldolase. Bioorg Med Chem (2006) 1.62
Control of the etric acid cycle by glyoxylate. I. A new inhibitor of aconitase formed by the condensation of glyoxylate with oxaloacetate. Biochem J (1962) 1.62
Reaction mechanism of Escherichia coli dihydrodipicolinate synthase investigated by X-ray crystallography and NMR spectroscopy. Biochemistry (1997) 1.62
The crystal structure of three site-directed mutants of Escherichia coli dihydrodipicolinate synthase: further evidence for a catalytic triad. J Mol Biol (2004) 1.48
Crystal structure and kinetic study of dihydrodipicolinate synthase from Mycobacterium tuberculosis. Biochem J (2008) 1.46
Crystal structure of dihydrodipicolinate synthase (BA3935) from Bacillus anthracis at 1.94 A resolution. Proteins (2006) 1.40
Metabolism of gamma-hydroxyglutamic acid. I. Conversion to alpha-hydroxy-gamma-ketoglutarate by purified glutamic-aspartic transaminase to rat liver. J Biol Chem (1962) 1.30
Structure and mechanism of a sub-family of enzymes related to N-acetylneuraminate lyase. J Mol Biol (1997) 1.28
The structural basis for substrate promiscuity in 2-keto-3-deoxygluconate aldolase from the Entner-Doudoroff pathway in Sulfolobus solfataricus. J Biol Chem (2004) 1.23
Pathways of hepatic oxalate synthesis and their regulation. Am J Physiol (1997) 1.15
Identification and characterization of HAOX1, HAOX2, and HAOX3, three human peroxisomal 2-hydroxy acid oxidases. J Biol Chem (2000) 1.14
Directed evolution of a new catalytic site in 2-keto-3-deoxy-6-phosphogluconate aldolase from Escherichia coli. Structure (2001) 1.13
Microbial aldolases as C-C bonding enzymes--unknown treasures and new developments. Appl Microbiol Biotechnol (2006) 1.13
ENZYMATIC STEPS IN THE CONVERSION OF GAMMA-HYDROXYGLUTAMATE TO GLYOXYLATE AND ALANINE. J Biol Chem (1963) 1.11
Insight into the self-association of key enzymes from pathogenic species. Eur Biophys J (2005) 1.09
Role of arginine 138 in the catalysis and regulation of Escherichia coli dihydrodipicolinate synthase. Biochemistry (2005) 1.07
Genetic evidence for a common enzyme catalyzing the second step in the degradation of proline and hydroxyproline. J Clin Invest (1979) 1.05
Correction of an enzyme trafficking defect in hereditary kidney stone disease in vitro. Biochem J (2003) 1.03
Purification, crystallization and characterization of N-acetylneuraminate lyase from Escherichia coli. Biochem J (1991) 1.00
A bacterial selection for the directed evolution of pyruvate aldolases. Bioorg Med Chem (2004) 0.98
2-Keto-4-hydroxyglutarate aldolase: purification and characterization of the homogeneous enzyme from bovine kidney. J Biol Chem (1992) 0.95
Specificity of the D-amino acid oxidase in relation to glycine oxidase activity. J Biol Chem (1962) 0.94
Mutagenesis of the phosphate-binding pocket of KDPG aldolase enhances selectivity for hydrophobic substrates. Protein Sci (2007) 0.91
Rat liver 4-hydroxy-2-ketoglutarate aldolase: purification and kinetic characterization. Arch Biochem Biophys (1985) 0.90
The high-resolution structure of dihydrodipicolinate synthase from Escherichia coli bound to its first substrate, pyruvate. Acta Crystallogr Sect F Struct Biol Cryst Commun (2008) 0.89
How essential is the 'essential' active-site lysine in dihydrodipicolinate synthase? Biochimie (2010) 0.89
PURIFICATION AND PROPERTIES OF RAT LIVER 2-KETO-4-HYDROXYGLUTARATE ALDOLASE. J Biol Chem (1964) 0.88
Crystal structure and stereochemical studies of KD(P)G aldolase from Thermoproteus tenax. Proteins (2008) 0.87
Specificity versus catalytic potency: The role of threonine 44 in Escherichia coli dihydrodipicolinate synthase mediated catalysis. Biochimie (2009) 0.86
Mutating the tight-dimer interface of dihydrodipicolinate synthase disrupts the enzyme quaternary structure: toward a monomeric enzyme. Biochemistry (2008) 0.84
Beef liver 2-keto-4-hydroxyglutarate aldolase: substrate stereospecificity and Schiff base formation with pyruvate and glyoxylate. Biochem Biophys Res Commun (1966) 0.84
4-Hydroxyproline metabolism and glyoxylate production: A target for substrate depletion in primary hyperoxaluria? Kidney Int (2006) 0.84
Characterization and crystal structure of Escherichia coli KDPGal aldolase. Bioorg Med Chem (2007) 0.82
Disruption of quaternary structure in Escherichia coli dihydrodipicolinate synthase (DHDPS) generates a functional monomer that is no longer inhibited by lysine. Arch Biochem Biophys (2010) 0.81
Steady-state kinetics and inhibition studies of the aldol condensation reaction catalyzed by bovine liver and Escherichia coli 2-keto-4-hydroxyglutarate aldolase. Biochemistry (1981) 0.77
4-hydroxy-2-ketoglutarate aldolase of rat liver. Purification, binding of substrates, and kinetic properties. J Biol Chem (1967) 0.77
The C-terminal domain of Escherichia coli dihydrodipicolinate synthase (DHDPS) is essential for maintenance of quaternary structure and efficient catalysis. Biochem Biophys Res Commun (2009) 0.77
Peptide methionine sulfoxide reductase: structure, mechanism of action, and biological function. Arch Biochem Biophys (2002) 2.76
Dimers to doughnuts: redox-sensitive oligomerization of 2-cysteine peroxiredoxins. Biochemistry (2002) 2.41
Co-Occurrence of Substance-Related and Other Mental Health Disorders Among Adolescent Cannabis Users. J Addict Med (2015) 2.03
Endothelial epsin deficiency decreases tumor growth by enhancing VEGF signaling. J Clin Invest (2012) 1.87
Impact of sodium-hydrogen exchange inhibition by cariporide on death or myocardial infarction in high-risk CABG surgery patients: results of the CABG surgery cohort of the GUARDIAN study. J Thorac Cardiovasc Surg (2003) 1.64
The impact of dietary calcium and oxalate ratios on stone risk. Urology (2012) 1.60
Overexpression of methyl-CpG binding protein 2 impairs T(H)1 responses. Sci Transl Med (2012) 1.56
Structure of the sulphiredoxin-peroxiredoxin complex reveals an essential repair embrace. Nature (2008) 1.52
Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol (2002) 1.49
Hydroxyproline metabolism in mouse models of primary hyperoxaluria. Am J Physiol Renal Physiol (2011) 1.49
Identification of a sequence in human toll-like receptor 5 required for the binding of Gram-negative flagellin. J Biol Chem (2003) 1.47
Glyoxylate reductase activity in blood mononuclear cells and the diagnosis of primary hyperoxaluria type 2. Nephrol Dial Transplant (2006) 1.44
Glycolate and glyoxylate metabolism in HepG2 cells. Am J Physiol Cell Physiol (2004) 1.38
Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat. Nat Struct Mol Biol (2007) 1.37
Use of dimedone-based chemical probes for sulfenic acid detection evaluation of conditions affecting probe incorporation into redox-sensitive proteins. Methods Enzymol (2010) 1.33
Flagellin-F1-V fusion protein is an effective plague vaccine in mice and two species of nonhuman primates. Clin Vaccine Immunol (2008) 1.33
An iron-binding protein, Dpr, from Streptococcus mutans prevents iron-dependent hydroxyl radical formation in vitro. J Bacteriol (2002) 1.32
Free methionine-(R)-sulfoxide reductase from Escherichia coli reveals a new GAF domain function. Proc Natl Acad Sci U S A (2007) 1.31
The increased incidence of pure red cell aplasia with an Eprex formulation in uncoated rubber stopper syringes. Kidney Int (2005) 1.31
Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics. Urology (2012) 1.29
Pepsin and carbonic anhydrase isoenzyme III as diagnostic markers for laryngopharyngeal reflux disease. Laryngoscope (2004) 1.23
Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. Ann Thorac Surg (2008) 1.21
Fatty acid synthase inhibitors: new directions for oncology. Expert Opin Investig Drugs (2007) 1.18
Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion. J Urol (2011) 1.16
Integrin conformational regulation: uncoupling extension/tail separation from changes in the head region by a multiresolution approach. Structure (2008) 1.16
Epoetin-associated pure red cell aplasia in patients with chronic kidney disease: solving the mystery. Nephrol Dial Transplant (2005) 1.16
Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin. Nitric Oxide (2008) 1.14
Identification of intact protein thiosulfinate intermediate in the reduction of cysteine sulfinic acid in peroxiredoxin by human sulfiredoxin. J Biol Chem (2008) 1.09
Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes. J Endourol (2011) 1.09
G4 resolvase 1 tightly binds and unwinds unimolecular G4-DNA. Nucleic Acids Res (2011) 1.09
Structural basis for the retroreduction of inactivated peroxiredoxins by human sulfiredoxin. Biochemistry (2005) 1.09
Increased protein intake on controlled oxalate diets does not increase urinary oxalate excretion. Urol Res (2009) 1.09
The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease. Urolithiasis (2013) 1.08
The peroxiredoxin repair proteins. Subcell Biochem (2007) 1.08
Reduction of cysteine sulfinic acid in peroxiredoxin by sulfiredoxin proceeds directly through a sulfinic phosphoryl ester intermediate. J Biol Chem (2008) 1.08
Inner-city asthma: the role of the community. Chest (2007) 1.08
Kinetic and spectroscopic characterization of the H178A methionyl aminopeptidase from Escherichia coli. Biochemistry (2003) 1.07
Structure, stability, and interaction of the fibrin(ogen) alphaC-domains. Biochemistry (2009) 1.07
Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design. Am Heart J (2007) 1.06
Off-Pump versus Conventional Coronary Artery Bypass Grafting: A Meta-Analysis and Consensus Statement From The 2004 ISMICS Consensus Conference. Innovations (Phila) (2005) 1.06
Mitochondrial hydroxyproline metabolism: implications for primary hyperoxaluria. Am J Nephrol (2005) 1.04
Metabolism of [13C5]hydroxyproline in vitro and in vivo: implications for primary hyperoxaluria. Am J Physiol Gastrointest Liver Physiol (2011) 1.03
Effect of soda consumption on urinary stone risk parameters. J Endourol (2009) 1.02
Active site and loop 4 movements within human glycolate oxidase: implications for substrate specificity and drug design. Biochemistry (2008) 1.01
The mechanical properties of individual, electrospun fibrinogen fibers. Biomaterials (2008) 1.01
The thioredoxin domain of Neisseria gonorrhoeae PilB can use electrons from DsbD to reduce downstream methionine sulfoxide reductases. J Biol Chem (2006) 1.00
Glyoxal formation and its role in endogenous oxalate synthesis. Adv Urol (2012) 0.99
NMR solution structure, stability, and interaction of the recombinant bovine fibrinogen alphaC-domain fragment. Biochemistry (2007) 0.98
Quantitative assessment of citric acid in lemon juice, lime juice, and commercially-available fruit juice products. J Endourol (2008) 0.98
Mitochondrial peroxiredoxin 3 is more resilient to hyperoxidation than cytoplasmic peroxiredoxins. Biochem J (2009) 0.98
Continuity of care is good for elderly people with diabetes: retrospective cohort study of mortality and hospitalization. Can Fam Physician (2011) 0.97
Protein engineering of the quaternary sulfiredoxin.peroxiredoxin enzyme.substrate complex reveals the molecular basis for cysteine sulfinic acid phosphorylation. J Biol Chem (2009) 0.97
Continuity of care for older patients in family practice: how important is it? Can Fam Physician (2006) 0.96
Molecular basis for the resistance of human mitochondrial 2-Cys peroxiredoxin 3 to hyperoxidation. J Biol Chem (2013) 0.95
4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition. Biochim Biophys Acta (2012) 0.94
LDL particle core enrichment in cholesteryl oleate increases proteoglycan binding and promotes atherosclerosis. J Lipid Res (2013) 0.93
Expression and purification of integral membrane fatty acid desaturases. PLoS One (2013) 0.92
On the mechanism of αC polymer formation in fibrin. Biochemistry (2012) 0.92
Metabolism of primed, constant infusions of [1,2-¹³C₂] glycine and [1-¹³C₁] phenylalanine to urinary oxalate. Metabolism (2010) 0.91
5-Oxo-ETE analogs and the proliferation of cancer cells. Biochim Biophys Acta (2005) 0.91
Variability of Oxalobacter formigenes and oxalate in stool samples. J Urol (2007) 0.90
Self-association and lipid binding properties of the lipoprotein initiating domain of apolipoprotein B. J Biol Chem (2006) 0.90
Action of reactive oxygen species on colonic mucus secretions. Free Radic Biol Med (2007) 0.90
C60-fullerenes: detection of intracellular photoluminescence and lack of cytotoxic effects. J Nanobiotechnology (2006) 0.89
Endothelial cells organize fibrin clots into structures that are more resistant to lysis. Microsc Microanal (2005) 0.87
Aggregation of normal and sickle hemoglobin in high concentration phosphate buffer. Biophys J (2004) 0.87
Mutations in the PX-SH3A linker of p47phox decouple PI(3,4)P2 binding from NADPH oxidase activation. Biochemistry (2008) 0.85
Structural and functional characterization of monomeric EphrinA1 binding site to EphA2 receptor. J Biol Chem (2012) 0.84
The association of cardiovascular disease and metabolic syndrome with nephrolithiasis. Curr Opin Urol (2012) 0.83
Behavioural and substance use problems in rural and urban delinquent youths. Can J Psychiatry (2003) 0.81
Intestinal and renal handling of oxalate loads in normal individuals and stone formers. Urol Res (2007) 0.80
Genetic and dietary factors in urinary citrate excretion. J Endourol (2005) 0.80
A novel ligand delivery system to non-invasively visualize and therapeutically exploit the IL13Rα2 tumor-restricted biomarker. Neuro Oncol (2012) 0.78
PROBING αIIbβ3: LIGAND INTERACTIONS BY DYNAMIC FORCE SPECTROSCOPY AND SURFACE PLASMON RESONANCE. Nano Life (2013) 0.78
Hemostatic properties and the role of cell receptor recognition in human hair keratin protein hydrogels. Biomaterials (2013) 0.78
Physiological changes associated with aging and immobility. J Aging Res (2012) 0.77
Our elderly population feels well. They are in control and not burdening their caregivers. Can Fam Physician (2004) 0.77
A review of Internet-based home drug-testing products for parents. Pediatrics (2004) 0.77
Oxalate and sucralose absorption in idiopathic calcium oxalate stone formers. Urology (2011) 0.77
Multibacterial growth from a surgical renal stone culture: a case report and literature review. Rev Urol (2012) 0.76